期刊文献+

葛根素磷脂复合物的制备及其固体分散体研究 被引量:41

Studies on Preparation of Puerarin Phytosomes and Their Solid Dispersions
下载PDF
导出
摘要 目的优化葛根素磷脂复合物的制备工艺,研究其固体分散体,提高葛根素的体外溶出速率。方法采用正交设计优化复合物制备工艺,以溶剂法制备葛根素磷脂复合物与聚乙烯吡咯烷酮(PVP)的共沉淀物;以体外溶出度法考察不同配比PVP共聚物胶囊的药物累积溶出度。结果葛根素磷脂复合物的优化制备条件为:无水乙醇作溶剂,卵磷脂为药物的1.2倍,30℃搅拌0.5 h。3种不同pH介质中,葛根素的溶解度分别提高了2.08,1.42和1.82倍,油水表观分配系数分别提高了1.11,1.25和1.30倍;葛根素磷脂复合物与PVP(质量比为1∶3)共沉淀物胶囊在人工胃液和pH 6.8磷酸盐缓冲液中的累积溶出度明显高于物理混合物及磷脂复合物。结论磷脂可提高葛根素的溶解度、油水表观分配系数,葛根素磷脂复合物-PVP共沉淀物可提高葛根素磷脂复合物的体外溶出;而葛根素磷脂复合物-PVP共沉淀物的体内过程有待进一步研究。 OBJECTIVE To optimize preparation techniques for puerarin phytosomes and explore their solid dispersions to increase the dissolution of puerarin in vitro .METHODS The preparation conditions for puerarin phytosomes were optimized by means of orthogonal de- sign, and the puemrin-phytosome-PVP coprecipitates were prepared by means of solvent evaporation. The accumulative dissolution rate of puerarin in coprecipitates with different ratios of puerarin-phytosomes to PVP was investigated according to dissolution release in vitro. RESULTS The optimized preparation conditions for puerarin phytosomes were obtained as follows. Solvent was ethanol. The ratio of puerarin to phospholipid was 1 to 1.2.Temperature was 30℃ .Reaction time was 0.5 h.The solubility of puerarin was enhanced by 2.08, 1.42 and 1.82 times in three media with different pH and its oil/water apparent partition coefficient was also enhanced by 1.11, 1.25 and 1.30 times respectively by phos- pholipid. The accumulative dis,solution rate of puemrin-phytosome-PVP coprecipitate(ratio of mass was 1 to 3) was significantly higher than that of its physical mixture and puerarin phytosome. CONCLUSION Phospholipid can effectively enhance the solubility and oil/water appartent partition coefficient of puevarin, and the coprecipitate of puerarin-phytosome and PVP can improve its dissolution in vitro, but the pharmacokinetics needs further study.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第15期1162-1167,共6页 Chinese Pharmaceutical Journal
关键词 葛根素 磷脂复合物 聚乙烯吡咯烷酮共沉淀物 胶囊 puerarin phytosome PVP coprecipitate capsule
  • 相关文献

参考文献8

  • 1GABETTA E,BOMBAROELLI E,PIFFERL G.Complexes of flavanolignanes with phospholipids,preparation there of and associated pharmaceutical composition.Patent No,0209038[P].1987-01-21.
  • 2WUJM CHENDW ZHANGRH etal.The review of the pharmaceutical study on the natural active component—phospholipid complex[J].中国药学杂志,1998,33(1):9-11.
  • 3CHEN D C.Handbook of Chemical Standard Sample of Tradational Chinese Drug(中药化学对照品工作手册)[M].Beijing:ChinaMedico-Pharmaceutical Science and Technology Publishing House,2000.
  • 4施邑屏,黎燕斌,孙玲玲,冯青,李祖义.^(31)P核磁共振光谱及薄层色谱分析针剂大豆卵磷脂[J].分析化学,1991,19(7):733-736. 被引量:26
  • 5BOMBARDELLI E,BIANCHETTI G.Pharmaceutical and cosmetic compositions containing complexes of flavanoligans with phospholipid.Patent No,0300282[P].1989-01-25.
  • 6BOMBARDELLI E,SPELTA M.Aging skin:protective effect of silymarin-phytosome[J].Fitoterapia,1991,62(2):115-119.
  • 7吴建梅,陈大为,刘艳丽.黄芩苷磷脂复合物制备工艺的研究[J].中国中药杂志,2001,26(3):166-169. 被引量:38
  • 8BI D Z.Pharmaceutics(药剂学)[M].Beijing:People's Medical Publishing House,1997.

二级参考文献12

  • 1毛凤斐 屠锡德.黄芩苷人体内吸收研究[J].中成药研究,1981,(12):6-9.
  • 2毛凤斐 屠锡德 等.黄芩苷大鼠小肠吸收的研究[J].南京药学院学报,1984,15(1):61-61.
  • 3毛凤斐 朱家璧 等.黄芩苷人体内吸收研究[J].南京药院学报,1983,21(1):61-61.
  • 4天津大学物理化学教研室.物理化学(第三版)下册[M].北京:高等教育出版社,1993.340.
  • 5毛凤斐 朱家璧 屠锡德等.黄芩苷在人体内吸收的研究.南京药学院学报,1983,21(1):61-66.
  • 6天津大学物理化学教研室,物理化学.下(第3版),1993年,340页
  • 7Bombardelli E,European Patent Application 0 441 2 79A1,1991年
  • 8沈建民,药物结构与制剂,1989年,61页
  • 9Gabetta B,European Patent Application 0 2 0 9 0 3 8,1987年
  • 10毛凤斐,南京药学院学报,1984年,15卷,1期,61页

共引文献62

同被引文献517

引证文献41

二级引证文献300

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部